Randolph S. Marshall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Randolph S. Marshall has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Amani M. Norling
The Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, 02131, Massachusetts, USA
1 shared publication Amy Huang
Department of Neurology, Stroke Division, Columbia University, New York, NY
1 shared publicationAndres Reccius
Department of Critical Care, Clinica Alemana, Universidad del Desarrollo, Santiago, Chile
1 shared publication- Arjun Vijay Masurkar
Department of Neurology, NYU Grossman School of Medicine, 145 East 32nd Street, New York, NY 10016, USA
1 shared publication - Brajesh K. Lal
Department of Vascular Surgery (BKL), University of Maryland, Baltimore, USA
1 shared publication - David Sigmund Liebeskind
Department of Neurology, University of Southern California, Los Angeles, CA
1 shared publication
Latest Publications
- 19 January 2019
- Published by Springer Nature in Current Cardiology Reports
- Vol. 21 (1) , 1-10
Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment?
Purpose of Review To review the current literature that supports the notion that cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of vascular cognitive impairment that is amenable to treatment by revascularization. Recent Findings Converging evidence suggests that successful carotid endarterectomy and carotid artery stenting are associated with reversal of cognitive decline in many patients with severe but asymptomatic carotid artery stenosis. Most of these findings have been derived from cohort studies and comparisons with either normal or surgical controls. Failure to find treatment benefit in a number of studies appears to have been the result of patient heterogeneity or confounding from concomitant conditions independently associated with cognitive decline, such as heart failure and other cardiovascular risk factors, or failure to establish pre-procedure hemodynamic failure. Summary Patients with severe carotid artery stenosis causing cerebral hemodynamic impairment may have a reversible cause of cognitive decline. None of the prior studies, however, were done in the context of a randomized clinical trial with large numbers of participants. The ongoing CREST-2 trial comparing revascularization with medical therapy versus medical therapy alone, and its associated CREST-H study determining whether cognitive decline is reversible among those with hemodynamic compromise may address this question.
- 19 January 2019
- Published by Springer Nature in Current Cardiology Reports
- Vol. 21 (1) , 1-10
Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment?
Purpose of Review To review the current literature that supports the notion that cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of vascular cognitive impairment that is amenable to treatment by revascularization. Recent Findings Converging evidence suggests that successful carotid endarterectomy and carotid artery stenting are associated with reversal of cognitive decline in many patients with severe but asymptomatic carotid artery stenosis. Most of these findings have been derived from cohort studies and comparisons with either normal or surgical controls. Failure to find treatment benefit in a number of studies appears to have been the result of patient heterogeneity or confounding from concomitant conditions independently associated with cognitive decline, such as heart failure and other cardiovascular risk factors, or failure to establish pre-procedure hemodynamic failure. Summary Patients with severe carotid artery stenosis causing cerebral hemodynamic impairment may have a reversible cause of cognitive decline. None of the prior studies, however, were done in the context of a randomized clinical trial with large numbers of participants. The ongoing CREST-2 trial comparing revascularization with medical therapy versus medical therapy alone, and its associated CREST-H study determining whether cognitive decline is reversible among those with hemodynamic compromise may address this question.
- 5 November 2014
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 17 (1) , 1-10
Strategies for Early Stroke Recovery: What Lies Ahead?
Most patients experience some degree of recovery after a stroke, but the majority of patients still have persistent impairments months later. Most recovery occurs early after a stroke, in the first few weeks to months, corresponding to a period of enhanced neuroplasticity. We are beginning to understand the mechanisms that underlie this recovery process, and how we can take advantage of this plasticity in designing rehabilitative interventions. In this review, we focus on recent behavioral, pharmacological, and brain stimulation strategies that have shown promise in augmenting stroke recovery. Several studies, both in animals and humans, suggest that early initiation and high doses of therapy are crucial for maximizing the benefits of rehabilitation. The investigation of early and intensive therapy in clinical trials has been limited, likely due to the logistical challenges of conducting such studies. Other strategies for promoting recovery seek to modulate neuroplasticity or to enhance the effects of rehabilitation, including the use of pharmacological agents, stem cell therapy and non-invasive brain stimulation. While there has been recent growth in stroke recovery and rehabilitation research, there is still a great need for more basic science and clinical research to further our understanding of the stroke recovery process and develop optimal rehabilitative strategies for promoting stroke recovery.
- 5 November 2014
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 17 (1) , 1-10
Strategies for Early Stroke Recovery: What Lies Ahead?
Most patients experience some degree of recovery after a stroke, but the majority of patients still have persistent impairments months later. Most recovery occurs early after a stroke, in the first few weeks to months, corresponding to a period of enhanced neuroplasticity. We are beginning to understand the mechanisms that underlie this recovery process, and how we can take advantage of this plasticity in designing rehabilitative interventions. In this review, we focus on recent behavioral, pharmacological, and brain stimulation strategies that have shown promise in augmenting stroke recovery. Several studies, both in animals and humans, suggest that early initiation and high doses of therapy are crucial for maximizing the benefits of rehabilitation. The investigation of early and intensive therapy in clinical trials has been limited, likely due to the logistical challenges of conducting such studies. Other strategies for promoting recovery seek to modulate neuroplasticity or to enhance the effects of rehabilitation, including the use of pharmacological agents, stem cell therapy and non-invasive brain stimulation. While there has been recent growth in stroke recovery and rehabilitation research, there is still a great need for more basic science and clinical research to further our understanding of the stroke recovery process and develop optimal rehabilitative strategies for promoting stroke recovery.
- 22 April 2013
- Published by Wiley in Journal of Neuroimaging
- Vol. 24 (4) , 379-386
Reliability, Asymmetry, and Age Influence on Dynamic Cerebral Autoregulation Measured by Spontaneous Fluctuations of Blood Pressure and Cerebral Blood Flow Velocities in Healthy Individuals
BACKGROUND Cerebral autoregulation (CA) enables the brain to maintain stable cerebral blood flow (CBF). CA can be assessed noninvasively by determining correlations between CBF velocity (CBFV) and spontaneous changes in blood pressure. Postrecording signal analysis methods have included both frequency‐ and time‐domain methods. However, the test‐retest reliability, cross‐validation, and determination of normal values have not been adequately established. METHODS In 53 healthy volunteers, a transfer function analysis was applied to calculate phase shift (PS) and gain in the low frequency range (.06‐.12 Hz) where CA is most apparent. Correlation analysis was used to derive mean velocity index (Mx). Intraclass correlation and bivariate correlation coefficients were applied to assess asymmetry, cross‐validity, and test‐retest results: The bihemispheric average PS, gain, and Mx means were 45.99+/−14.24°, .62+/−.38 cm/second/mmHg, and .41+/−.13, respectively. Gain exhibited a difference by age (P = .03). PS, gain, and Mx values showed excellent interhemispheric correlation (r > .8; P < .001). PS and gain showed good reliability (R ICC = .632, L ICC = .576; P < .001). PS and Mx showed fair correlation (r = −.37; P < .001). CONCLUSIONS CA parameters obtained by time‐ and frequency‐domain methods correlate well, and show good interhemispheric and test‐retest reliability. Group means from healthy controls may provide adequate norms for determining abnormal CA in cerebrovascular patients.
- 22 April 2013
- Published by Wiley in Journal of Neuroimaging
- Vol. 24 (4) , 379-386
Reliability, Asymmetry, and Age Influence on Dynamic Cerebral Autoregulation Measured by Spontaneous Fluctuations of Blood Pressure and Cerebral Blood Flow Velocities in Healthy Individuals
BACKGROUND Cerebral autoregulation (CA) enables the brain to maintain stable cerebral blood flow (CBF). CA can be assessed noninvasively by determining correlations between CBF velocity (CBFV) and spontaneous changes in blood pressure. Postrecording signal analysis methods have included both frequency‐ and time‐domain methods. However, the test‐retest reliability, cross‐validation, and determination of normal values have not been adequately established. METHODS In 53 healthy volunteers, a transfer function analysis was applied to calculate phase shift (PS) and gain in the low frequency range (.06‐.12 Hz) where CA is most apparent. Correlation analysis was used to derive mean velocity index (Mx). Intraclass correlation and bivariate correlation coefficients were applied to assess asymmetry, cross‐validity, and test‐retest results: The bihemispheric average PS, gain, and Mx means were 45.99+/−14.24°, .62+/−.38 cm/second/mmHg, and .41+/−.13, respectively. Gain exhibited a difference by age (P = .03). PS, gain, and Mx values showed excellent interhemispheric correlation (r > .8; P < .001). PS and gain showed good reliability (R ICC = .632, L ICC = .576; P < .001). PS and Mx showed fair correlation (r = −.37; P < .001). CONCLUSIONS CA parameters obtained by time‐ and frequency‐domain methods correlate well, and show good interhemispheric and test‐retest reliability. Group means from healthy controls may provide adequate norms for determining abnormal CA in cerebrovascular patients.